- This event has passed.
Webinar: How to rapidly select and characterize antibodies with SPR
February 26 @ 14:00 - 14:30
Mark your calendar and attend Nicoyas webinar to learn how you can rapidly select and characterize antibodies with SPR.
Over 100 million cases of COVID-19 are currently reported worldwide, and viral viriants are in circulation. The pandemic has accellerated the need for scientific discoveries in terms of novel therapeutics, vaccines, and diagnostic solutions.
A core tenet of viral research lies in the comprehension of how COVID-19 interact with biological targets and protective antibodies. In their upcoming webinar, the innovative and reputable Nicoya teaches you how surface plasmon resonance (SPR) has been widely adopted for label-free biomolecular characterization. In their webinar, Nicoya demonstrates the application of the powerful technique with a study on developing a novel COVID-19 diagnostic assay.
Nicoya teaches you:
- Why SPR is ideal for several biomolecular applications
- How SPR-based characterization benefits studies for accelerating lead time on novel COVID-19 solutions
- How to maximize performance and optimize COVID-19 antigen detection by developing a selective and specific antibody pair with SPR
- How the next generation of SPR platforms advances label-free detection to address the unmet needs of infectious disease research.
Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. They offer state-of-the-art surface plasmon resonance (SPR) instrument for a fraction of the cost of existing solutions delivering highly sensitive kinetic data. Read more about Nicoya here.